Deutsche Bank
IRD

Deutsche Bank’s Opus Genetics IRD Stock Holding History

Deutsche Bank’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,400
Closed -$7K – 4719
2021
Q2 		$7K Buy
+1,400
New +$6.95K ﹤0.01% 4490
2020
Q1 		– Sell
-375
Closed -$2K – 4900
2019
Q4 		$2K Buy
+375
New +$2.83K ﹤0.01% 4859
2017
Q3 		– Sell
-35
Closed -$4K – 5119
2017
Q2 		$4K Buy
+35
New +$6.8K ﹤0.01% 4784
2015
Q2 		– Sell
-10
Closed -$3K – 5491
2015
Q1 		$3K Sell
10
-82
-89% -$29.8K ﹤0.01% 4960
2014
Q4 		$30K Sell
92
-127
-58% -$43.9K ﹤0.01% 5375
2014
Q3 		$85K Buy
219
+6
+3% +$2.16K ﹤0.01% 4604
2014
Q2 		$88K Buy
+213
New +$96.8K ﹤0.01% 4640

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's IRD Position: Q3 2021 in Review

Deutsche Bank sold out of Opus Genetics (IRD) in Q3 2021, closing a stake of 1,400 shares — an estimated $7K sold.

Deutsche Bank first reported a position in IRD in Q2 2014 and held it in 7 quarters. The position peaked at $88K in Q2 2014. 30 funds tracked by Wall St. Rank hold IRD as of Q3 2021.

  • Deutsche Bank reported no remaining Opus Genetics position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 1,400 Opus Genetics shares in Q3 2021, an estimated $7K.
  • Deutsche Bank first reported a position in Opus Genetics in Q2 2014 and held it in 7 quarters.
  • Deutsche Bank's Opus Genetics position peaked at $88K in Q2 2014.
  • 30 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.